700 related articles for article (PubMed ID: 21454665)
21. Loss of SS18-SSX1 inhibits viability and induces apoptosis in synovial sarcoma.
Carmody Soni EE; Schlottman S; Erkizan HV; Uren A; Toretsky JA
Clin Orthop Relat Res; 2014 Mar; 472(3):874-82. PubMed ID: 23716114
[TBL] [Abstract][Full Text] [Related]
22. The SYT protein involved in the t(X;18) synovial sarcoma translocation is a transcriptional activator localised in nuclear bodies.
Brett D; Whitehouse S; Antonson P; Shipley J; Cooper C; Goodwin G
Hum Mol Genet; 1997 Sep; 6(9):1559-64. PubMed ID: 9285794
[TBL] [Abstract][Full Text] [Related]
23. Cloning and characterization of spliced fusion transcript variants of synovial sarcoma: SYT/SSX4, SYT/SSX4v, and SYT/SSX2v. Possible regulatory role of the fusion gene product in wild type SYT expression.
Brodin B; Haslam K; Yang K; Bartolazzi A; Xie Y; Starborg M; Lundeberg J; Larsson O
Gene; 2001 May; 268(1-2):173-82. PubMed ID: 11368913
[TBL] [Abstract][Full Text] [Related]
24. Induction of p21(WAF1/CIP1) by human synovial sarcoma-associated chimeric oncoprotein SYT-SSX1.
Tsuda M; Watanabe T; Seki T; Kimura T; Sawa H; Minami A; Akagi T; Isobe K; Nagashima K; Tanaka S
Oncogene; 2005 Dec; 24(54):7984-90. PubMed ID: 16103879
[TBL] [Abstract][Full Text] [Related]
25. PIASy mediates NEMO sumoylation and NF-kappaB activation in response to genotoxic stress.
Mabb AM; Wuerzberger-Davis SM; Miyamoto S
Nat Cell Biol; 2006 Sep; 8(9):986-93. PubMed ID: 16906147
[TBL] [Abstract][Full Text] [Related]
26. Detection of SYT-SSX fusion transcripts in archival synovial sarcomas by real-time reverse transcriptase-polymerase chain reaction.
Bijwaard KE; Fetsch JF; Przygodzki R; Taubenberger JK; Lichy JH
J Mol Diagn; 2002 Feb; 4(1):59-64. PubMed ID: 11826189
[TBL] [Abstract][Full Text] [Related]
27. Characterization of a variant SYT-SSX1 synovial sarcoma fusion transcript.
Safar A; Wickert R; Nelson M; Neff JR; Bridge JA
Diagn Mol Pathol; 1998 Oct; 7(5):283-7. PubMed ID: 9990487
[TBL] [Abstract][Full Text] [Related]
28. SYT-SSX fusion genes in synovial sarcoma of the thorax.
Yano M; Toyooka S; Tsukuda K; Dote H; Morimoto Y; Ohata N; Ichimura K; Aoe M; Date H; Shimizu N
Lung Cancer; 2004 Jun; 44(3):391-7. PubMed ID: 15140553
[TBL] [Abstract][Full Text] [Related]
29. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2; q11.2) and the cell cycle machinery.
Xie Y; Skytting B; Nilsson G; Grimer RJ; Mangham CD; Fisher C; Shipley J; Bjerkehagen B; Myklebost O; Larsson O
Oncogene; 2002 Aug; 21(37):5791-6. PubMed ID: 12173050
[TBL] [Abstract][Full Text] [Related]
30. Detection of a variant SYT-SSX1 fusion in a case of predominantly epithelioid synovial sarcoma.
Sanders ME; van de Rijn M; Barr FG
Mol Diagn; 1999 Mar; 4(1):65-70. PubMed ID: 10229776
[TBL] [Abstract][Full Text] [Related]
31. Molecular mechanisms underlying human synovial sarcoma development.
dos Santos NR; de Bruijn DR; van Kessel AG
Genes Chromosomes Cancer; 2001 Jan; 30(1):1-14. PubMed ID: 11107170
[TBL] [Abstract][Full Text] [Related]
32. In silico and in vitro screening of small molecule Inhibitors against SYT-SSX1 fusion protein in synovial sarcoma.
Natarajan V; Ramanathan P; Gopisetty G; Ramachandran B; Thangarajan R; Kesavan S
Comput Biol Chem; 2018 Dec; 77():36-43. PubMed ID: 30219714
[TBL] [Abstract][Full Text] [Related]
33. Are there geographical differences in the frequency of SYT-SSX1 and SYT-SSX2 chimeric transcripts in synovial sarcoma?
Koković I; Bracko M; Golouh R; Ligtenberg M; van Krieken HJ; Hudler P; Komel R
Cancer Detect Prev; 2004; 28(4):294-301. PubMed ID: 15350633
[TBL] [Abstract][Full Text] [Related]
34. Detection of SYT-SSX rearrangements in synovial sarcomas by real-time one-step RT-PCR.
Nikiforova MN; Groen P; Mutema G; Nikiforov YE; Witte D
Pediatr Dev Pathol; 2005; 8(2):162-7. PubMed ID: 15747098
[TBL] [Abstract][Full Text] [Related]
35. [Analysis of SYT/SSX1 and SYT/SSX2 fusion genes from synovial sarcoma].
Kekeeva TV; Riazantseva AA; Zavalishina LÉ; Andreeva IuIu; Babenko OV; Zaletaev DV; Frank GA
Mol Biol (Mosk); 2011; 45(5):840-4. PubMed ID: 22393780
[TBL] [Abstract][Full Text] [Related]
36. Association of SYT-SSX fusion types with proliferative activity and prognosis in synovial sarcoma.
Inagaki H; Nagasaka T; Otsuka T; Sugiura E; Nakashima N; Eimoto T
Mod Pathol; 2000 May; 13(5):482-8. PubMed ID: 10824918
[TBL] [Abstract][Full Text] [Related]
37. Targeting the Wnt pathway in synovial sarcoma models.
Barham W; Frump AL; Sherrill TP; Garcia CB; Saito-Diaz K; VanSaun MN; Fingleton B; Gleaves L; Orton D; Capecchi MR; Blackwell TS; Lee E; Yull F; Eid JE
Cancer Discov; 2013 Nov; 3(11):1286-301. PubMed ID: 23921231
[TBL] [Abstract][Full Text] [Related]
38. The synovial sarcoma-associated SYT-SSX2 oncogene antagonizes the polycomb complex protein Bmi1.
Barco R; Garcia CB; Eid JE
PLoS One; 2009; 4(4):e5060. PubMed ID: 19337376
[TBL] [Abstract][Full Text] [Related]
39. The impact of chromosomal translocation locus and fusion oncogene coding sequence in synovial sarcomagenesis.
Jones KB; Barrott JJ; Xie M; Haldar M; Jin H; Zhu JF; Monument MJ; Mosbruger TL; Langer EM; Randall RL; Wilson RK; Cairns BR; Ding L; Capecchi MR
Oncogene; 2016 Sep; 35(38):5021-32. PubMed ID: 26947017
[TBL] [Abstract][Full Text] [Related]
40. The E3 SUMO ligase PIASy is a regulator of cellular senescence and apoptosis.
Bischof O; Schwamborn K; Martin N; Werner A; Sustmann C; Grosschedl R; Dejean A
Mol Cell; 2006 Jun; 22(6):783-794. PubMed ID: 16793547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
